| Patient |
Gender |
Smoking status at time of TL |
Previous malignancy |
Chemotherapy |
| 1 |
M |
Former |
T0N2M0SCC of left neck |
Concurrent cisplatin |
| 2 |
M |
Former |
T2N2bM0 SCC of right pyriform sinus |
No |
| 3 |
M |
Former |
T3N3M0 SCC of right tonsil |
Induction TIP |
| 4 |
M |
Current |
T4N0M0 SCC of soft palate |
Concurrent cisplatin |
| 5 |
M |
Former |
T4N2cM0 SCC of left tonsil |
Concurrent cisplatin |
| 6 |
M |
Former |
T2N0M0 SCC of right TVF |
No |
| 7 |
F |
Former |
T4N2CM0 SCC of posterior pharyngeal wall |
Concurrent cisplatin |
| 8 |
M |
Never |
T2N0M0 SCC of right arytenoid |
No |
| 9 |
M |
Former |
T1N0M0 SCC of left false vocal fold |
No |
| 10 |
M |
Former |
T1N0M0 SCC of right TVF |
No |
| 11 |
M |
Former |
T2N3M0 SCC of left TVF extending up onto epiglottis |
Concurrent cisplatin |
| 12 |
M |
Current |
SCC of right TVF with subglottic extension |
No |
| 13 |
F |
Current |
T2N0M0 SCC of left TVF |
Concurrent cisplatin |
| 14 |
M |
Former |
T1N2a SCC of right AE fold |
No |
| 15 |
F |
Former |
T2N2bM0 SCC of right false vocal fold |
Concurrent cisplatin |
| 16 |
M |
Current |
T1N1M0 SCC of BOT |
Concurrent cisplatin |
| 17 |
M |
Current |
T2N0M0 SCC of left AE fold |
No |
| 18 |
M |
Former |
SCC of unknown primary to right neck |
No |
| 19 |
M |
Never |
Medullary thyroid cancer |
No |
|
20 |
M |
Former |
SCC of unknown primary, followed by right lateral pharyngeal wall |
Concurrent cisplatin |
|
21 |
M |
Never |
T4N2cM0 nasopharyngeal carcinoma |
Induction and concurrent cisplatin |
|
22 |
M |
Former |
T3N0M0 SCC of right tonsil; CIS of pharyngeal wall, epiglottis, base of tongue, and vallecula |
No |
| 23 |
M |
Former |
T2N2aM0 SCC of left pyriform sinus |
Induction TIC |
| 24 |
M |
Former |
T3N2bM0 SCC of posterior oral tongue/BOT |
Concurrent carboplatin |
SCC-squamous cell carcinoma; TVF-true vocal fold; AE-aryepiglottic; BOT-base of tongue; CIS-carcinoma in situ; TIP-Taxol, Ifosfamide, Cisplatin; TIC-Taxol,
Ifosfamide, Carboplatin